These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 12760377)
41. An Arato I; Luca G; Mancuso F; Bellucci C; Lilli C; Calvitti M; Hansen BC; Milardi D; Grande G; Calafiore R Asian J Androl; 2018; 20(2):160-165. PubMed ID: 29148520 [TBL] [Abstract][Full Text] [Related]
42. Activin-βC modulates gonadal, but not adrenal tumorigenesis in the inhibin deficient mice. Marino FE; Risbridger G; Gold E Mol Cell Endocrinol; 2015 Jul; 409():41-50. PubMed ID: 25869398 [TBL] [Abstract][Full Text] [Related]
43. Sertoli cell proliferations of the infantile testis: an intratubular form of Sertoli cell tumor? Venara M; Rey R; Bergadá I; Mendilaharzu H; Campo S; Chemes H Am J Surg Pathol; 2001 Oct; 25(10):1237-44. PubMed ID: 11688457 [TBL] [Abstract][Full Text] [Related]
44. The Sertoli cell hormones inhibin-B and anti Müllerian hormone have different patterns of secretion in prepubertal cryptorchid boys. Cortes D; Clasen-Linde E; Hutson JM; Li R; Thorup J J Pediatr Surg; 2016 Mar; 51(3):475-80. PubMed ID: 26452703 [TBL] [Abstract][Full Text] [Related]
46. Inhibin, activin, and follistatin in human fetal pituitary and gonadal physiology. Blumenfeld Z; Ritter M Ann N Y Acad Sci; 2001 Sep; 943():34-48. PubMed ID: 11594553 [TBL] [Abstract][Full Text] [Related]
47. Inhibin secretion in the stallion. Nagata S; Miyake YI; Nambo Y; Nagamine N; Watanabe G; Tsunoda N; Taniyama H; Hondo E; Yamada J; Taya K Equine Vet J; 1998 Mar; 30(2):98-103. PubMed ID: 9535064 [TBL] [Abstract][Full Text] [Related]
49. A novel transgenic model to characterize the specific effects of follicle-stimulating hormone on gonadal physiology in the absence of luteinizing hormone actions. Allan CM; Haywood M; Swaraj S; Spaliviero J; Koch A; Jimenez M; Poutanen M; Levallet J; Huhtaniemi I; Illingworth P; Handelsman DJ Endocrinology; 2001 Jun; 142(6):2213-20. PubMed ID: 11356665 [TBL] [Abstract][Full Text] [Related]
50. Interrelationship of growth differentiation factor 9 and inhibin in early folliculogenesis and ovarian tumorigenesis in mice. Wu X; Chen L; Brown CA; Yan C; Matzuk MM Mol Endocrinol; 2004 Jun; 18(6):1509-19. PubMed ID: 15016837 [TBL] [Abstract][Full Text] [Related]
51. The pattern of inhibin/activin alpha- and betaB-subunit messenger ribonucleic acid expression in rat testis after selective Leydig cell destruction by ethylene dimethane sulfonate. Tena-Sempere M; Kero J; Rannikko A; Yan W; Huhtaniemi I Endocrinology; 1999 Dec; 140(12):5761-70. PubMed ID: 10579342 [TBL] [Abstract][Full Text] [Related]
52. What have we learned about gonadotropin function from gonadotropin subunit and receptor knockout mice? Kumar TR Reproduction; 2005 Sep; 130(3):293-302. PubMed ID: 16123236 [TBL] [Abstract][Full Text] [Related]
53. Cell-specific transcriptional regulation of follicle-stimulating hormone-beta by activin and gonadotropin-releasing hormone in the LbetaT2 pituitary gonadotrope cell model. Pernasetti F; Vasilyev VV; Rosenberg SB; Bailey JS; Huang HJ; Miller WL; Mellon PL Endocrinology; 2001 Jun; 142(6):2284-95. PubMed ID: 11356674 [TBL] [Abstract][Full Text] [Related]
54. Neonatal administration of FSH increases Sertoli cell numbers and spermatogenesis in gonadotropin-deficient (hpg) mice. Singh J; Handelsman DJ J Endocrinol; 1996 Oct; 151(1):37-48. PubMed ID: 8943767 [TBL] [Abstract][Full Text] [Related]
55. Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. Matzuk MM; Finegold MJ; Mather JP; Krummen L; Lu H; Bradley A Proc Natl Acad Sci U S A; 1994 Sep; 91(19):8817-21. PubMed ID: 8090730 [TBL] [Abstract][Full Text] [Related]
56. Testicular anti-mullerian hormone secretion is stimulated by recombinant human FSH in patients with congenital hypogonadotropic hypogonadism. Young J; Chanson P; Salenave S; Noël M; Brailly S; O'Flaherty M; Schaison G; Rey R J Clin Endocrinol Metab; 2005 Feb; 90(2):724-8. PubMed ID: 15536161 [TBL] [Abstract][Full Text] [Related]
57. Transgenic mouse models for gonadal tumorigenesis. Rahman NA; Kananen Rilianawati K; Paukku T; Mikola M; Markkula M; Hämäläinen T; Huhtaniemi IT Mol Cell Endocrinol; 1998 Oct; 145(1-2):167-74. PubMed ID: 9922114 [TBL] [Abstract][Full Text] [Related]
58. Decay of follicle-stimulating hormone-beta messenger RNA in the presence of transcriptional inhibitors and/or inhibin, activin, or follistatin. Attardi B; Winters SJ Mol Endocrinol; 1993 May; 7(5):668-80. PubMed ID: 7686252 [TBL] [Abstract][Full Text] [Related]
59. Characterization of inhibin/activin subunit, follistatin, and activin type II receptors in human ovarian cancer cell lines: a potential role in autocrine growth regulation. Di Simone N; Crowley WF; Wang QF; Sluss PM; Schneyer AL Endocrinology; 1996 Feb; 137(2):486-94. PubMed ID: 8593793 [TBL] [Abstract][Full Text] [Related]
60. The isolation and physiology of inhibin and related proteins. de Kretser DM; Robertson DM Biol Reprod; 1989 Jan; 40(1):33-47. PubMed ID: 2493821 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]